Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2021 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 in vitro

  • Authors:
    • Huifang Liu
    • Junzhi Sun
    • Li Gao
    • Lingling Fan
    • Dongmei Chen
    • Lifang Wu
  • View Affiliations / Copyright

    Affiliations: Department of Anesthesiology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010000, P.R. China
  • Article Number: 527
    |
    Published online on: May 25, 2021
       https://doi.org/10.3892/mmr.2021.12166
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The exact pathogenesis of acute lung injury (ALI) has not been fully clarified. Previous studies have demonstrated that ALI is associated with inflammation. Recent studies have demonstrated that microRNA‑421 (miR‑421) prevents inflammation in cerebellar ischemia reperfusion injury. However, the role of miR‑421 in ALI remains unclear. The present study investigated the role of miR‑421 in ALI and the mechanism underlying this. ALI was induced in vitro by treatment of RAW 264.7 macrophages with lipopolysaccharide (LPS). Cells were then transfected with miR‑421 mimic, miR‑421 mimic control, programmed cell death 4 (PDCD4) siRNA and PDCD4 siRNA control using Lipofectamine 2000. Cell viability was measured using the Cell Counting kit‑8. Reverse transcription‑quantitative polymerase chain reaction was used to detect the expression of miR‑421 and PDCD4 in RAW 264.7 macrophages. The concentrations of IL‑1β and TNF‑α were detected by ELISA. Dual‑luciferase reporter assays were used to investigate the interaction between miR‑421 and PDCD4 mRNA. LPS inhibited cell viability and miR‑421 expression. The miR‑421 mimic promoted RAW 264.7 cell viability and inhibited the expression of iNOS and COX‑2 as well as the release of IL‑1β and TNF‑α. PDCD4 siRNA inhibited the expression of iNOS and COX‑2 expression as well as the release of IL‑1β and TNF‑α. In addition, miR‑421 mimic and PDCD4 siRNA inhibit the expression of p‑NF‑κB (p65) in RAW 264.7 cells. In conclusion, the present study demonstrated the protective effect of miR‑421 on ALI and showed that miR‑421 attenuates LPS‑induced ALI by inhibiting PDCD4 and NF‑κB. These findings provided a theoretical basis for the treatment of ALI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Szabo C, Martins V and Liaudet L: Poly(ADP-Ribose) polymerase inhibition in acute lung injury. A reemerging concept. Am J Respir Cell Mol Biol. 63:571–590. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Needham DM, Colantuoni E, Mendez-Tellez PA, Dinglas VD, Sevransky JE, Dennison Himmelfarb CR, Desai SV, Shanholtz C, Brower RG and Pronovost PJ: Lung protective mechanical ventilation and two year survival in patients with acute lung injury: Prospective cohort study. BMJ. 344:e21242012. View Article : Google Scholar : PubMed/NCBI

3 

Reagan-Steiner S, Gary J, Matkovic E, Ritter JM, Shieh WJ, Martines RB, Werner AK, Lynfield R, Holzbauer S, Bullock H, et al: Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): A case series. Lancet Respir Med. 8:1219–1232. 2020. View Article : Google Scholar : PubMed/NCBI

4 

Do-Umehara H, Chen C, Urich D, Zhou L, Qiu J, Jang S, Zander A, Baker MA, Eilers M, Sporn PH, et al: Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ. Nat Immunol. 14:461–469. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Vlaar AP and Juffermans NP: Transfusion-related acute lung injury: A clinical review. Lancet. 382:984–994. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Needham DM, Dinglas VD, Morris PE, Jackson JC, Hough CL, Mendez-Tellez PA, Wozniak AW, Colantuoni E, Ely EW, Rice TW, et al: Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med. 188:567–576. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Witwer KW and Halushka MK: Toward the promise of microRNAs-enhancing reproducibility and rigor in microRNA research. RNA Biol. 13:1103–1116. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Rezaei S, Mahjoubin-Tehran M, Aghaee-Bakhtiari SH, Jalili A, Movahedpour A, Khan H, Moghoofei M, Shojaei Z R, Hamblin M and Mirzaei H: Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. Crit Rev Oncol Hematol. 153:1030632020. View Article : Google Scholar : PubMed/NCBI

9 

Cushing L, Jiang Z, Kuang P and Lü J: The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases. Am J Respir Cell Mol Biol. 52:397–408. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Shen Z, Xuan W, Wang H, Sun F, Zhang C, Gong Q and Ge S: miR-200b regulates cellular senescence and inflammatory responses by targeting ZEB2 in pulmonary emphysema. Artif Cells Nanomed Biotechnol. 48:656–663. 2020. View Article : Google Scholar : PubMed/NCBI

11 

Liang Z, Xu J, Ma Z, Li G and Zhu W: miR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 11:70–80. 2020. View Article : Google Scholar : PubMed/NCBI

12 

Shi S and Li H: Overexpressed microRNA-140 inhibits pulmonary fibrosis in interstitial lung disease via the Wnt signaling pathway by downregulating osteoglycin. Am J Physiol Cell Physiol. 319:C895–C905. 2020. View Article : Google Scholar : PubMed/NCBI

13 

Huang Y, Huang L, Zhu G, Pei Z and Zhang W: Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway. J Cell Physiol. 234:6023–6032. 2019. View Article : Google Scholar : PubMed/NCBI

14 

Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J and Luo Z: MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 17:2001–2018. 2018. View Article : Google Scholar : PubMed/NCBI

15 

Wu CT, Huang Y, Pei ZY, Xi X and Zhu GF: MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-κB signaling pathway. Int J Biochem Cell Biol. 101:1–11. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Zheng L, Tang X, Lu M, Sun S, Xie S, Cai J and Zan J: microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A reader YTHDF1 to inhibit p65 mRNA translation. Int Immunopharmacol. 88:1069372020. View Article : Google Scholar : PubMed/NCBI

17 

Jiang F, Zhou HY, Zhou LF, Wen YH, Gai HH and Wu GM: MicroRNA-421 promotes inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis by targeting SPRY1. Eur Rev Med Pharmacol Sci. 23:8186–8193. 2019.PubMed/NCBI

18 

Yuan HS, Xiong DQ, Huang F, Cui J and Luo H: MicroRNA-421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10. J Cell Biochem. 120:16876–16887. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Lee MR, Kim JE, Park JJ, Choi JY, Song BR, Choi YW, Kim DS, Kim KM, Song HK and Hwang DY: Protective role of fermented mulberry leave extract in LPS-induced inflammation and autophagy of RAW264.7 macrophage cells. Mol Med Rep. 22:4685–4695. 2020. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Wu D, Zhang H, Wu Q, Li F, Wang Y, Liu S and Wang J: Sestrin 2 protects against LPS-induced acute lung injury by inducing mitophagy in alveolar macrophages. Life Sci. 267:1189412020. View Article : Google Scholar : PubMed/NCBI

22 

Tang L, Gao XH, Zhao B, Luo JR, Shi XY, Ge R, Ban SR and Li QS: Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI). Bioorg Med Chem. 28:1157332020. View Article : Google Scholar : PubMed/NCBI

23 

Li G, Dai Y, Tan J, Zou J, Nie X, Yang Z, Zhao J, Yang X and Chen J: SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysaccharide-induced acute lung injury. Mol Med Rep. 22:1656–1662. 2020. View Article : Google Scholar : PubMed/NCBI

24 

Shaikh SB and Prabhakar Bhandary Y: Effect of curcumin on IL-17A mediated pulmonary AMPK kinase/cyclooxygenase-2 expressions via activation of NFκB in bleomycin-induced acute lung injury in vivo. Int Immunopharmacol. 85:1066762020. View Article : Google Scholar : PubMed/NCBI

25 

Yang HH, Duan JX, Liu SK, Xiong JB, Guan XX, Zhong WJ, Sun CC, Zhang CY, Luo XQ, Zhang YF, et al: A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics. 10:4749–4761. 2020. View Article : Google Scholar : PubMed/NCBI

26 

Butt Y, Kurdowska A and Allen T: Acute lung injury: A clinical and molecular review. Arch Pathol Lab Med. 140:345–350. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Deng JC and Standiford TJ: Growth factors and cytokines in acute lung injury. Compr Physiol. 1:81–104. 2011.PubMed/NCBI

28 

Li X, Ye C, Mulati M, Sun L and Qian F: Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. Biochem Pharmacol. 177:1139922020. View Article : Google Scholar : PubMed/NCBI

29 

Wang X, Yan J, Xu X, Duan C, Xie Z, Su Z, Ma H, Ma H, Wei X and Du X: Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response. Microb Pathog. 118:170–176. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Liang Y, Luo J, Yang N, Wang S, Ye M and Pan G: Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury. Biosci Rep. 40:BSR201935722020. View Article : Google Scholar : PubMed/NCBI

31 

Nosaka N, Martinon D, Moreira D, Crother TR, Arditi M and Shimada K: Autophagy protects against developing increased lung permeability and hypoxemia by down regulating inflammasome activity and IL-1β in LPS plus mechanical ventilation-induced acute lung injury. Front Immunol. 11:2072020. View Article : Google Scholar : PubMed/NCBI

32 

Yang YN, Bian LQ, Ling XD, Fang CY and Jiang SL: MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4. Pathol Res Pract. 215:1525552019. View Article : Google Scholar : PubMed/NCBI

33 

Li JW, Wei L, Han Z and Chen Z: Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 852:68–76. 2019. View Article : Google Scholar : PubMed/NCBI

34 

Al-Harbi NO, Imam F, Al-Harbi MM, Ansari MA, Zoheir KM, Korashy HM, Sayed-Ahmed MM, Attia SM, Shabanah OA and Ahmad SF: Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunol Invest. 45:349–369. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu H, Sun J, Gao L, Fan L, Chen D and Wu L: MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>. Mol Med Rep 24: 527, 2021.
APA
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., & Wu, L. (2021). MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>. Molecular Medicine Reports, 24, 527. https://doi.org/10.3892/mmr.2021.12166
MLA
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., Wu, L."MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>". Molecular Medicine Reports 24.1 (2021): 527.
Chicago
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., Wu, L."MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>". Molecular Medicine Reports 24, no. 1 (2021): 527. https://doi.org/10.3892/mmr.2021.12166
Copy and paste a formatted citation
x
Spandidos Publications style
Liu H, Sun J, Gao L, Fan L, Chen D and Wu L: MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>. Mol Med Rep 24: 527, 2021.
APA
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., & Wu, L. (2021). MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>. Molecular Medicine Reports, 24, 527. https://doi.org/10.3892/mmr.2021.12166
MLA
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., Wu, L."MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>". Molecular Medicine Reports 24.1 (2021): 527.
Chicago
Liu, H., Sun, J., Gao, L., Fan, L., Chen, D., Wu, L."MicroRNA‑421 attenuates macrophage‑mediated inflammation by inhibiting PDCD4 <em>in vitro</em>". Molecular Medicine Reports 24, no. 1 (2021): 527. https://doi.org/10.3892/mmr.2021.12166
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team